EDNS.F Stock Overview
Develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Eden Research plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.05 |
| 52 Week High | UK£0.05 |
| 52 Week Low | UK£0.05 |
| Beta | 0.94 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| EDNS.F | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -1.2% |
| 1Y | n/a | 9.3% | 30.4% |
Return vs Industry: Insufficient data to determine how EDNS.F performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how EDNS.F performed against the US Market.
Price Volatility
| EDNS.F volatility | |
|---|---|
| EDNS.F Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: EDNS.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine EDNS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 19 | Sean Smith | www.edenresearch.com |
Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products.
Eden Research plc Fundamentals Summary
| EDNS.F fundamental statistics | |
|---|---|
| Market cap | US$23.66m |
| Earnings (TTM) | -US$1.93m |
| Revenue (TTM) | US$4.99m |
4.7x
P/S Ratio-12.3x
P/E RatioIs EDNS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EDNS.F income statement (TTM) | |
|---|---|
| Revenue | UK£3.94m |
| Cost of Revenue | UK£2.01m |
| Gross Profit | UK£1.93m |
| Other Expenses | UK£3.45m |
| Earnings | -UK£1.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0029 |
| Gross Margin | 48.97% |
| Net Profit Margin | -38.70% |
| Debt/Equity Ratio | 0% |
How did EDNS.F perform over the long term?
See historical performance and comparison